4.6 Review

Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis

Journal

CANCERS
Volume 14, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/cancers14081864

Keywords

ZEB1; post-translational modifications; epithelial-to-mesenchymal transition (EMT); metastasis; epigenetic; transcription factor

Categories

Funding

  1. CPRIT-MIRA RP160652-P3 [NCI R37CA214609]
  2. Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research [NIH NCI F31CA268343]

Ask authors/readers for more resources

This review paper focuses on the post-translational modifications (PTMs) of the transcription factor ZEB1 and their role in tumor progression through the epithelial-to-mesenchymal transition (EMT). It outlines the current knowledge and raises unanswered questions regarding the regulation of ZEB1-targeted gene expression. The research covered in this review contributes to improving our understanding of ZEB1-mediated EMT and developing new treatment strategies for cancer.
Simple Summary Given the importance of the epithelial-to-mesenchymal transition in tumor progression and the pivotal role of ZEB1 as a transcriptional repressor during this process, the regulation of ZEB1-targeted gene expression is an active area of investigation. Diverse signaling pathways converge to induce ZEB1 activity, but few studies have focused on the enzyme-dependent modifications of ZEB1 that occur after its translation from mRNA (i.e., post-translational modifications, PTM). In addition to outlining the current knowledge in the field, we outline several questions regarding the PTM-mediated regulation of ZEB1 that remain unanswered. Thus, the areas of research covered in this review paper will provide a noteworthy conceptual advancement in our understanding of ZEB1 ' s biological function, as well as its post-transcriptional and post-translational regulation. Furthermore, the review will enhance the development of treatment strategies by identifying knowledge gaps in ZEB1 ' s regulatory mechanisms that could potentially be targeted to prevent and treat metastasis in cancer patients. Zinc finger E-box binding homeobox 1 (ZEB1) is a pleiotropic transcription factor frequently expressed in carcinomas. ZEB1 orchestrates the transcription of genes in the control of several key developmental processes and tumor metastasis via the epithelial-to-mesenchymal transition (EMT). The biological function of ZEB1 is regulated through pathways that influence its transcription and post-transcriptional mechanisms. Diverse signaling pathways converge to induce ZEB1 activity; however, only a few studies have focused on the molecular associations or functional changes of ZEB1 by post-translational modifications (PTMs). Due to the robust effect of ZEB1 as a transcription repressor of epithelial genes during EMT, the contribution of PTMs in the regulation of ZEB1-targeted gene expression is an active area of investigation. Herein, we review the pivotal roles that phosphorylation, acetylation, ubiquitination, sumoylation, and other modifications have in regulating the molecular associations and behavior of ZEB1. We also outline several questions regarding the PTM-mediated regulation of ZEB1 that remain unanswered. The areas of research covered in this review are contributing to new treatment strategies for cancer by improving our mechanistic understanding of ZEB1-mediated EMT.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available